T. Scott Stroup, MD, MPH

Expertise in: 
Depression, Anxiety Disorders
Board Certifications: 
Psychiatry
Accepting New Patients
Profile Headshot

Overview

Areas of Expertise / Conditions Treated

Depression, Anxiety Disorders, Psychotic Disorders

Academic Appointments

  • Professor of Psychiatry

Administrative Titles

  • Vice Chair for Academic Affairs and Faculty Development, Department of Psychiatry
  • Director, Optimizing and Personalizing Interventions for Schizophrenia Across the Lifespan (OPAL) Center

T. Scott Stroup, MD, MPH, is a Professor of Psychiatry at Columbia University Vagelos College of Physicians and Surgeons. Dr. Stroup's research focuses on the effectiveness of interventions and services for people diagnosed with schizophrenia and related illnesses. He was co-principal investigator of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study. He conducts research examining treatment strategies for schizophrenia.

He is principal investigator of the OPAL Center, a National Institute of Mental Health center that focuses on examining interventions that have real-world applications. His other interests include global mental health and the dissemination of evidence-based practices.

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Empire Blue Cross Blue Shield

  • NYP Employee Plan

UnitedHealthcare

  • Behavioral Health
  • Behavioral Health Columbia University Employee Plan

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • MD, University of North Carolina at Chapel Hill School of Medicine
  • MPH, University of North Carolina at Chapel Hill
  • Internship: Cambridge Health Alliance, Harvard Medical School
  • Residency: Cambridge Health Alliance, Harvard Medical School

Board Certifications

  • Psychiatry

Research

Research Interests

  • Psychotic Disorders

Grants

Comparative Effectiveness of Adaptive Pharmacotherapy Strategies for Schizophrenia-PCORI (Patient-Centered Outcomes Research Institute)

1-Jul-15 to 30-Jun-18

IMPROVING COGNITION VIA EXERCISE IN SCHIZOPHRENIA (Federal Gov)

Sep 15 2017 - Jul 31 2021

NOVEL PHARMACOTHERAPY STRATEGIES FOR OBESITY IN SCHIZOPHRENIA (Federal Gov)

Apr 15 2016 - Mar 31 2020

COMPARATIVE EFFECTIVENESS OF ADAPTIVE PHARMACOTHERAPY STRATEGIES FOR SCHIZOPHRENIA (Private)

Jul 1 2015 - Jun 30 2018

BEHAVIORAL HEALTH COLLABORATIVE RESEARCH GROUP FOR PCORNET (Private)

Jan 1 2017 - Nov 14 2017

CENTER FOR EDUCATION AND RESEARCH ON MENTAL HEALTH THERAPEUTICS (Federal Gov)

Sep 30 2011 - Aug 31 2016

1/2 - A COMPARISON OF LONG-ACTING INJECTABLE MEDICATIONS FOR SCHIZOPHRENIA (ACLAIMS) (Federal Gov)

Apr 1 2015 - Mar 31 2016

2/2 A COMPARISON OF LONG-ACTING INJECTABLE MEDICATIONS FOR SCHIZOPHRENIA-ACLAIMS (Federal Gov)

Jul 9 2009 - Mar 31 2016

SELF-DIRECTED CARE: TRANSFORMATION TRANSFER INITIATIVE (Federal Gov)

Feb 23 2014 - Sep 1 2014

PLASTICITY-BASED ADAPTIVE COGNITIVE REMEDIATION FOR SCHIZOPHRENIA (Federal Gov)

Aug 1 2011 - Sep 30 2013

LEARNING ADAPTIVE TREATMENT STRATEGIES IN MENTAL HEALTH (Federal Gov)

Sep 1 2009 - Apr 30 2012